A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/46 (2006.01) A61P 1/00 (2006.01) A61P 13/00 (2006.01) A61P 17/00 (2006.01) A61P 37/08 (2006.01)
Patent
CA 2441724
Atopic dermatitis is associated with abnormal intestinal permeability, as measured by fractional urinary excretion of sucrose as well as the lactulose/mannitol ratio. Treatment with pancreatic enzyme supplements (also referred to as pancreatin) (6 weeks) was associated with significantly improved atopic dermatitis (SCORAD index) as well as sucrose absorption.
Mccann Michael
Seidman Ernest G.
Singer Sanford
Gowling Lafleur Henderson Llp
Mccann Michael
Seidman Ernest G.
Singer Sanford
Solvay Pharma Inc.
LandOfFree
Treatment of regulation of atopic dermatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of regulation of atopic dermatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of regulation of atopic dermatitis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1434995